ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 янв 2023 17:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 дек 2022 17:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Updates

09 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Stifel 2022 Healthcare Conference

08 ноя 2022 07:01:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ноя 2022 17:38:22 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces First ZN-c3 Clinical Development Collaboration with Pfizer

24 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Mark Lackner as Chief Translational Officer, Head of Biomarker Strategy

17 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 окт 2022 17:32:42 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Promotes Co-Founder Kevin Bunker, Ph.D. to Chief Scientific Officer

27 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Carrie Brownstein as Chief Medical Officer

19 сен 2022 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Dr. Jan Skvarka to its Board of Directors

12 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 сен 2022 17:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

31 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Update

09 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference

03 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

01 авг 2022 17:10:35 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Appoints Andrea Paul as General Counsel and Corporate Secretary

27 июн 2022 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals to Participate in the Jefferies Healthcare Conference

01 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Promotes Cofounder Cam Gallagher to President

31 май 2022 07:00:00 Источник Nasdaq GlobeNewswire

Zentalis Pharmaceuticals Announces Closing of Underwritten Offering of Common Stock

18 май 2022 16:01:00 Источник Nasdaq GlobeNewswire